Toggle light / dark theme

Researchers devise new strategies to overcome a key CRISPR flaw

Posted in biotech/medical

It’s a long-debated flaw in CRISPR: When you try to give Cas9 to a patient to snip its DNA, that person’s immune system may recognize that the protein comes not from us but from our ancient microbial foes. And it might then attack.